Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Latest filing published 21 Jan 2026 for Cabaletta Bio, Inc., €43k.
Filing timeline
BuySaleShawn Tomasello
Insider track record
Disclosed buys
2
Disclosed sells
5
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +7.8%Entry US$2.94 · Close at T+90 US$3.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Shawn Tomasello: trading record in brief
This profile gathers the share dealings of Shawn Tomasello across 6 companies, led by Diplomat Pharmacy, Inc., Kite Pharma, Inc. and Gamida Cell Ltd. Between 20 December 2016 and 21 January 2026, the trades on record add up to 25 filings.
On the open market, the record shows 2 purchases worth €58k and 5 sales worth €921k. The net balance comes to €862k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 13 share grants. In 2026 alone, the filings show 1 purchase and no sales.
Most recently, on 21 January 2026, the filings show an open-market purchase worth €43k in Cabaletta Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shawn Tomasello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
22,725 shares@ US$2.2144100.0% of flowCommon StockSEC:0001193125-26-018324:0
Canonical exit: 21 Apr 2026 (T+90)
35,000 shares0Common StockSEC:0000950170-24-070596:0
200,000 shares0Ordinary SharesSEC:0001415889-24-002335:0
28,300 shares0Ordinary SharesSEC:0001209191-23-053265:0
35,000 shares0Common StockSEC:0001209191-23-029097:0
28,300 shares0Ordinary SharesSEC:0001209191-23-008551:0
2,000 shares0Ordinary SharesSEC:0001209191-22-058395:0
9,677 shares@ US$1.55100.0% of flowOrdinary SharesSEC:0001209191-22-052284:0
Canonical exit: 29 Dec 2022 (T+90)
35,938 shares0Common StockSEC:0001493152-20-009770:0
11,278 shares@ US$4.0024.7% of flowCommon StockSEC:0001104659-20-013515:0
33,259 shares@ US$4.0073.0% of flowCommon StockSEC:0001104659-20-013515:1
859 shares@ US$4.842.2% of flowCommon StockSEC:0001596771-19-000120:0
33,259 shares0Common StockSEC:0001596771-19-000057:0
1,274 shares@ US$4.852.7% of flowCommon StockSEC:0001596771-19-000057:1
2,275 shares0Common StockSEC:0001596771-18-000096:0
3,654 shares0Common StockSEC:0001596771-18-000072:0
1,680 shares@ US$24.27Common StockSEC:0001596771-18-000072:1
5,000 shares0Common StockSEC:0001209191-17-056222:0
16,135 shares@ US$180.00Common StockSEC:0001209191-17-056222:1
39,933 sharesCommon StockSEC:0001209191-17-056222:2
4,500 shares0Common StockSEC:0001209191-17-054200:0
4,203 shares@ US$179.66Common StockSEC:0001209191-17-054200:1
4,722 shares0Common StockSEC:0001596771-17-000046:0
10,600 shares0Common StockSEC:0001209191-16-156838:0
4,901 shares@ US$50.86Common StockSEC:0001209191-16-156550:0
25 of 25 declarations
